Abdominal aortic calcific deposits are associated with increased risk for congestive heart failure: The Framingham heart study

American Heart Journal

Volumn 144, Issue 4, 2002, Pages 733-739

  Walsh, Craig R ^a,c   Cupples, L Adrienne ^a,b   Levy, Daniel ^a,d,f   Kiel, Douglas P ^a,e   Hannan, Marian ^a,e   Wilson, Peter W F ^a   O'Donnell, Christopher J ^a,c,f  

^a FRAMINGHAM HEART STUDY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e RESEARCH AND TRAINING INSTITUTE   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL AORTA; ADULT; ARTERY CALCIFICATION; ARTICLE; ATHEROSCLEROSIS; CONGESTIVE HEART FAILURE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LUMBAR SPINAL CORD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RISK ASSESSMENT; RISK FACTOR; SPINE RADIOGRAPHY; STATISTICAL SIGNIFICANCE;

EID: 0036790154     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(02)00150-3     Document Type: Article

References (44)

1. McKee PA, Castelli WP, McNamara PM, et al. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971;285:1441-6.
2. Eriksson H, Svardsudd K, Larsson B, et al. Risk factors for heart failure in the general population: the study of men born in 1913. Eur Heart J 1989;10:647-56.
3. Remes J, Reunanen A, Aromaa A, et al. Incidence of heart failure in eastern Finland: a population-based surveillance study. Eur Heart J 1992;13:588-93.
4. Cowie MR, Wood DA, Coats AJ, et al. Incidence and aetiology of heart failure: a population-based study. Eur Heart J 1999;20:421-8.
5. Gottdiener JS, Arnold AM, Aurigemma GP, et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 2000;35:1628-37.
6. Wilson PW, Kauppila L, Kiel D, et al. Lumbar aortic calcification is an important predictor of vascular morbidity and mortality. Circulation 2001;103:1529-34.
7. Witteman JC, Kok FJ, van Saase JL, et al. Aortic calcification as a predictor of cardiovascular mortality. Lancet 1986;2:1120-2.
8. Iribarren C, Sidney S, Sternfeld B, et al. Calcification of the aortic arch: risk factors and association with coronary heart disease, stroke, and peripheral vascular disease. JAMA 2000;283:2810-5.
9. Blankenhorn DH, Kramsch DM. Reversal of atherosis and sclerosis: the two components of atherosclerosis. Circulation 1989;79:1-7.
10. Witteman JC, Grobbee DE, Valkenburg HA, et al. J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis. Lancet 1994;343:504-7.
11. Nichols WW, O'Rourke MF. Input impedance as vascular load. McDonald's blood flow in arteries. Theoretical, experimental, and clinical principles. 4th ed. New York: Oxford University Press; 1998. p. 284-92.
12. Saba PS, Roman MJ, Pini R, et al. Relation of arterial pressure waveform to left ventricular and carotid anatomy in normotensive subjects. J Am Coll Cardiol 1993;22:1873-80.
13. Rajkumar C, Cameron JD, Christophidis N, et al. Reduced systemic arterial compliance is associated with left ventricular hypertrophy and diastolic dysfunction in older people. J Am Geriatrics Soc 1997;45:803-8.
14. Chae CU, Pfeffer MA, Glynn RJ, et al. Increased pulse pressure and risk of heart failure in the elderly. JAMA 1999;281:634-43.
15. Hundley WG, Kitzman DW, Morgan TM, et al. Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance. J Am Coll Cardiol 2001;38:796-802.
16. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Natural history of aortic and coronary atherosclerotic lesions in youth. Findings from the PDAY Study. Arterioscler Thromb 1993;13:1291-8.
17. Kauppila LI, Polak JF, Cupples LA, et al. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis 1997;132:245-50.
18. Hyman JB, Epstein FH. A study of the correlation between roentgenographic and post-mortem calcification of the aorta. Am Heart J 1954;47:540-3.
19. Gordon T, Moore FE, Shurtleff D, et al. Some methodological problems in the long-term study of cardiovascular disease: observations on the Framingham Study. J Chronic Dis 1959;10:186-206.
20. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-46.
21. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-57.
22. Kannel WB, Gordon T, Offutt D. Left ventricular hypertrophy by electrocardiogram: prevalence, incidence, and mortality in the Framingham study. Ann Intern Med 1969;71:89-105.
23. Mosterd A, Deckers JW, Hoes AW, et al. Classification of heart failure in population based research: an assessment of six heart failure scores. Eur J Epidemiol 1997;13:491-502.
24. Marantz PR, Tobin JN, Wassertheil-Smoller S, et al. The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria. Circulation 1988;77:607-12.
25. Cox DR. Regression models and life tables. J R Stat Soc B 1972; 34:187-220.
26. Gheorghiade M, Bonow RO. Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation 1998;97:282-9.
27. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation 1990;81:1161-72.
28. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982;66:1146-9.
29. Braunwald E, Rutherford JD. Reversible ischemic left ventricular dysfunction: evidence for the "hibernating myocardium." J Am Coll Cardiol 1986;8:1467-70.
30. Khoury Z, Schwartz R, Gottlieb S, et al. Relation of coronary artery disease to atherosclerotic disease in the aorta, carotid, and femoral arteries evaluated by ultrasound. Am J Cardiol 1997;80:1429-33.
31. Farrar DJ, Bond MG, Riley WA, et al. Anatomic correlates of aortic pulse wave velocity and carotid artery elasticity during atherosclerosis progression and regression in monkeys. Circulation 1991;83:1754-63.
32. Wright JS, Cruickshank JK, Kontis S, et al. Aortic compliance measured by non-invasive Doppler ultrasound: description of a method and its reproducibility. Clin Sci 1990;78:463-8.
33. Mohiaddin RH, Underwood SR, Bogren HG, et al. Regional aortic compliance studied by magnetic resonance imaging: the effects of age, training, and coronary artery disease. Br Heart J 1989;62:90-6.
34. Shankar R, Bond MG. Correlation of noninvasive arterial compliance with anatomic pathology of atherosclerotic nonhuman primates. Atherosclerosis 1990;85:37-46.
35. Sherebrin MH, Kim HL, Roach MR. Calcium mass in human aortas from autopsy. Physiol Meas 1994;15:281-9.
36. Bridal SL, Fornes P, Bruneval P, et al. Correlation of ultrasonic attenuation (30 to 50 MHz) and constituents of atherosclerotic plaque. Ultrasound Med Biol 1997;23:691-703.
37. Jarvisalo MJ, Jartti L, Nanto-Salonen K, et al. Increased aortic intima-media thickness: a marker of preclinical atherosclerosis in high-risk children. Circulation 2001;104:2943-7.
38. Fayad ZA, Fuster V. Characterization of atherosclerotic plaques by magnetic resonance imaging. Ann N Y Acad Sci 2000;902:173-86.
39. Takasu J, Takanashi K, Naito S, et al. Evaluation of morphological changes of the atherosclerotic aorta by enhanced computed tomography. Atherosclerosis 1992;97:107-21.
40. The Studies of Left Ventricular Dysfunction Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators. N Engl J Med 1992;327:685-91.
41. Kober L, Torp-Pedersen C, Carlsen JE, et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med 1995;333:1670-6.
42. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-53.
43. Yusuf S, Pepine CJ, Garces C, et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 1992;340:1173-8.
44. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. The SAVE Investigators. N Engl J Med 1992;327:669-77.